HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE

Catalog No:
MBL-TS-M041-1
$1,470.00

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence VLSDFKTWL
Class Class I
Sequence Location 1992-2000
MHC Allele A*02:01

Documents & Links

Documents & Links for HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE
Datasheet HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE Datasheet

Documents & Links for HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE
Datasheet HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence VLSDFKTWL
Class Class I
Sequence Location 1992-2000
MHC Allele A*02:01

Documents & Links

Documents & Links for HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE
Datasheet HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE Datasheet

Documents & Links for HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE
Datasheet HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE Datasheet